UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000059100 |
|---|---|
| Receipt number | R000067609 |
| Scientific Title | Verification of the Impact of a Mutual Aid Platform on Disaster Resilience |
| Date of disclosure of the study information | 2025/09/17 |
| Last modified on | 2025/09/16 20:09:33 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Verification of the Impact of a Mutual Aid Platform on Disaster Resilience
Acronym
Disaster Prevention Effects of Mutual Aid Platforms
Scientific Title
Verification of the Impact of a Mutual Aid Platform on Disaster Resilience
Scientific Title:Acronym
Disaster Prevention Effects of Mutual Aid Platforms
Region
| Japan |
Condition
Condition
Insufficient self-care, low disaster preparedness awareness
Classification by specialty
| Nursing |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To develop and evaluate a mutual support platform that promotes self-help, mutual assistance, and self-care capacity, with the ultimate goal of enhancing disaster resilience.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Disaster ResilienceScale for Individuals, Self-Health Management Monitoring Scale for General Adults
Key secondary outcomes
Disaster Self-Efficacy Scale, Self Care Self-Efficacy Scale
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
YES
Dynamic allocation
NO
Institution consideration
Institution is not considered as adjustment factor.
Blocking
NO
Concealment
No need to know
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Behavior,custom |
Interventions/Control_1
Utilizing Mutual Aid Platforms
Platform Function 1: Aggregation and Sharing of Support-Needed Information (Locations/People)
Platform Function 2: Matching Support-Needed Locations/People with Supporters
Platform Function 3: Distribution of Health-Related Information
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Residents of the survey area
Key exclusion criteria
None
Target sample size
450
Research contact person
Name of lead principal investigator
| 1st name | Mie |
| Middle name | |
| Last name | Shiraishi |
Organization
The University of Osaka
Division name
Division of Health Sciences, Graduate School of Medicine
Zip code
5650871
Address
Yamadaoka, Suita-city, Osaka
TEL
06-6879-2536
mi-shi@sahs.med.osaka-u.ac.jp
Public contact
Name of contact person
| 1st name | Mie |
| Middle name | |
| Last name | Shiraishi |
Organization
The University of Osaka
Division name
Division of Health Sciences, Graduate School of Medicine
Zip code
5650871
Address
Yamadaoka, Suita-city, Osaka
TEL
06-6879-2536
Homepage URL
mi-shi@sahs.med.osaka-u.ac.jp
Sponsor or person
Institute
The University of Osaka
Institute
Department
Personal name
Mie Shiraishi
Funding Source
Organization
The University of Osaka
Organization
Division
Category of Funding Organization
Non profit foundation
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethics Review Committee, The University of Osaka Hospital
Address
2-2 Yamadaoka, Suita-city, Osaka
Tel
06-6210-8289
rinri@hp-crc.med.osaka-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 09 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2025 | Year | 09 | Month | 16 | Day |
Date of IRB
Anticipated trial start date
| 2025 | Year | 09 | Month | 28 | Day |
Last follow-up date
| 2026 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 09 | Month | 16 | Day |
Last modified on
| 2025 | Year | 09 | Month | 16 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067609
